How to Buy Ginkgo Bioworks Holdings Stock
Ginkgo Bioworks Holdings Inc
Spinning Eagle Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Ginkgo Bioworks Holdings stock last closed at $0.87, up 3.32% from the previous day, and has decreased 31.42% in one year. It has underperformed other stocks in the Biotechnology industry by 0.08 percentage points. Ginkgo Bioworks Holdings stock is currently +7.53% from its 52-week low of $0.81, and -65.78% from its 52-week high of $2.55.
At the moment, there are 2.15B DNA shares outstanding. The market value of DNA is $1.87B. In the last 24 hours, 55.35M DNA shares were traded.
How to Buy Ginkgo Bioworks Holdings Stock
Not sure how to invest in Ginkgo Bioworks Holdings stock? Here's how.
- Figure out where to buy Ginkgo Bioworks Holdings stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Ginkgo Bioworks Holdings stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your info.
- Research Ginkgo Bioworks Holdings stock: The Ginkgo Bioworks Holdings ticker symbol is DNA. Is Ginkgo Bioworks Holdings stock a good investment? Should you buy shares of DNA? How do DNA's underlying business fundamentals look? Do top analysts think Ginkgo Bioworks Holdings is a good buy? Why has DNA's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if DNA is a good stock to buy).
- Place your DNA trade: Decide if you will purchase DNA shares at the current market price or use a limit order to buy DNA shares at a particular price.
- Get notifications regarding your DNA investment: Create a watchlist to monitor your investment in Ginkgo Bioworks Holdings shares.
Step 1: Figure out where to buy Ginkgo Bioworks Holdings stock
You need a brokerage account to access the NYSE market and buy DNA stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Real Estate, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal info so you are able to buy DNA today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create your new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on app for investing, you need to deposit funds:
Watch the tutorial below for more details transferring money into your brokerage account.
Step 4: Research Ginkgo Bioworks Holdings stock
After you have identified the best place to buy Ginkgo Bioworks Holdings stock, it's crucial to research their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Ginkgo Bioworks Holdings shares quick numbers
DNA Fundamentals
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on DNA's stock page.
Is DNA stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge DNA's true value.
Using relative valuations methods:
- DNA could be undervalued based on its P/B ratio of 1.71x, relative to Biotechnology industry P/B ratio of 5.93x
You can do more valuation research on DNA's stock here.
DNA Financial Summary
Positive Health Checks:
- DNA has cash burn of 331873000. It has sufficient cash and short-term investments to cover this for at least one year.
- DNA has $944.07M in cash and short term investments. This is enough to cover its annual cash burn of $331.87M.
- There are more short-term assets than long-term liabilities on the DNA balance sheet.
- There are more short-term assets than short-term liabilities on the DNA balance sheet.
Negative Health Checks:
- DNA profit margin has gone up by 0.85 percentage points in the past year, but the company is still unprofitable.
- DNA has a relatively high debt to equity ratio of 0.52.
Do analysts think it's a good time to buy DNA stock
Out of 3 Wall Street analysts who give forecasts on DNA, the consensus analyst rating on Ginkgo Bioworks Holdings is a Hold
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Ginkgo Bioworks Holdings stock forecast page.
Metrics for Advanced DNA Traders
DNA Growth Numbers
Last year, DNA revenue was $251.46M. During the past 4 year, DNA's revenue has grown by 46.77% per year. This was faster than the Biotechnology industry average of 28.88%.
Learn more about DNA's earnings and revenue performance here.
Latest Insiders Trades at DNA
In the last 12 months, executives and large shareholders at DNA have sold more shares than they have bought.
Mark E. Dmytruk, Chief Financial Officer of DNA, was the latest DNA insider to sell. They sold $53,727.45 worth of DNA stock on Apr 2, 2024.
Get more info about who owns DNA shares here.
Does DNA stock generate passive income?
No, Ginkgo Bioworks Holdings doesn't provide an income stream by paying out dividends.
What do other investors have to say about DNA?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your DNA trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open Trade button and your broker will place your order.
If you require additional help buying stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your DNA investment
Now that you own some DNA shares, you'll want to stay up-to-date on your investment.
Start a watchlist to monitor your DNA stock.
DNA Feed
How to Buy Stock in Ginkgo Bioworks Holdings
To summarize, here are the 6 steps you need to take to buy Ginkgo Bioworks Holdings stock right now:
- Figure out where to buy Ginkgo Bioworks Holdings stock
- Create a brokerage account
- Deposit funds into your brokerage account
- Research Ginkgo Bioworks Holdings stock
- Place your DNA trade
- Get notifications regarding your DNA investment
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your new investment in Ginkgo Bioworks Holdings, hit the button below to create your watchlist.
Other Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.